Pharmaceutical Technology·· 6 days agoPickScore59
Roche bets on the RNAi approach for obesity through $1bn Rona deal
In brief
Through a deal with Rona worth around $1 billion, Roche joins a growing list of major pharmaceutical and biotech companies exploring RNAi therapy for obesity.
Why it matters
Roche enters RNAi obesity research through a $1 billion deal with Rona.
Source: Pharmaceutical Technology · pharmaceutical-technology.com